Get started
IQVIA HIQVIA HIQVIA H

IQVIA H

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Bonds

1IQV chart


Full chart

1IQV upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪23.97 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
20.25
Basic EPS (TTM)
7.35 EUR
Net income (FY)
‪1.33 B‬ EUR
Revenue (FY)
‪14.88 B‬ EUR
Shares float
‪174.78 M‬
Beta (1Y)
0.68

Employees


Employees (FY)
‪88 K‬
Change (1Y)
‪+1 K‬ +1.15%
Revenue / Employee (1Y)
‪169.10 K‬ EUR
Net income / Employee (1Y)
‪15.07 K‬ EUR

About IQVIA Holdings, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Ari Bousbib
Website
iqvia.com
Headquarters
Durham
Founded
1950
FIGI
BBG01TNXRC83
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1IQV news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1IQV highest yielding bonds


IQV5590191
IQVIA Inc. 6.5% 15-MAY-2030
Yield to maturity
6.23%
Maturity date
May 15, 2030
IQV5590192
IQVIA Inc. 6.5% 15-MAY-2030
Yield to maturity
5.83%
Maturity date
May 15, 2030
IQV4831576
IQVIA Inc. 5.0% 15-MAY-2027
Yield to maturity
5.37%
Maturity date
May 15, 2027
IQV5590167
IQVIA Inc. 5.7% 15-MAY-2028
Yield to maturity
5.22%
Maturity date
May 15, 2028
QTRN4404230
IQVIA Inc. 5.0% 15-OCT-2026
Yield to maturity
5.19%
Maturity date
Oct 15, 2026
IQV5763047
IQVIA Inc. 6.25% 01-FEB-2029
Yield to maturity
5.14%
Maturity date
Feb 1, 2029
IQV5590165
IQVIA Inc. 5.7% 15-MAY-2028
Yield to maturity
5.08%
Maturity date
May 15, 2028
5W8A
IQVIA 21/29 REGS
Yield to maturity
3.99%
Maturity date
Mar 15, 2029
XS218994750
IQVIA 20/28 REGS
Yield to maturity
3.94%
Maturity date
Jun 15, 2028
XS203679815
IQVIA 19/28 REGS
Yield to maturity
3.78%
Maturity date
Jan 15, 2028
XS168438745
IQVIA 17/25 REGS
Yield to maturity
3.75%
Maturity date
Sep 15, 2025

See all 1IQV bonds 


Check out other big names from the same industry as 1IQV.

Frequently Asked Questions


The current price of 1IQV is 134.55 EUR — it has decreased by −0.037% in the past 24 hours. Watch IQVIA H stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange IQVIA H stocks are traded under the ticker 1IQV.
1IQV stock has risen by 1.66% compared to the previous week, the month change is a 1.66% rise, over the last year IQVIA H has showed a 1.66% increase.
We've gathered analysts' opinions on IQVIA H future price: according to them, 1IQV price has a max estimate of 228.36 EUR and a min estimate of 140.53 EUR. Watch 1IQV chart and read a more detailed IQVIA H stock forecast: see what analysts think of IQVIA H and suggest that you do with its stocks.
1IQV reached its all-time high on Apr 30, 2025 with the price of 134.60 EUR, and its all-time low was 131.05 EUR and was reached on Apr 25, 2025. View more price dynamics on 1IQV chart.
See other stocks reaching their highest and lowest prices.
1IQV stock is 0.037% volatile and has beta coefficient of 0.68. Track IQVIA H stock price on the chart and check out the list of the most volatile stocks — is IQVIA H there?
Yes, you can track IQVIA H financials in yearly and quarterly reports right on TradingView.
IQVIA H is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
1IQV earnings for the last quarter are 3.01 EUR per share, whereas the estimation was 3.00 EUR resulting in a 0.35% surprise. The estimated earnings for the next quarter are 2.43 EUR per share. See more details about IQVIA H earnings.
IQVIA H revenue for the last quarter amounts to ‪3.82 B‬ EUR, despite the estimated figure of ‪3.79 B‬ EUR. In the next quarter, revenue is expected to reach ‪3.49 B‬ EUR.
1IQV net income for the last quarter is ‪422.13 M‬ EUR, while the quarter before that showed ‪255.97 M‬ EUR of net income which accounts for 64.91% change. Track more IQVIA H financial stats to get the full picture.
No, 1IQV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has ‪88 K‬ employees. See our rating of the largest employees — is IQVIA H on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IQVIA H EBITDA is ‪3.27 B‬ EUR, and current EBITDA margin is 21.96%. See more stats in IQVIA H financial statements.
Like other stocks, 1IQV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IQVIA H stock right from TradingView charts — choose your broker and connect to your account.